|1||NCT00890825||Completed||Comparison of AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive Non Small Cell Lung Cancer (NSCLC) Patients||
||422||All||18 Years to 130 Years (Adult, Senior)||NCT00890825||D1532C00016||April 2009||May 2011||November 2016||April 30, 2009||November 10, 2016||
|2||NCT02185690||Recruiting||A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung||
||Other / Industry||
||30||All||18 Years to 90 Years (Adult, Senior)||NCT02185690||CMEK162BCA01T||MEK162||January 11, 2018||March 2019||April 2019||July 9, 2014||February 5, 2018||
† Study has passed its completion date and status has not been verified in more than two years.